Conditions we treat
Ketamine and Bipolar Depression: A Careful Look
Ketamine for bipolar depression is being studied, but requires extra care and coordination with your psychiatrist. What the research says and what we watch for.
Bipolar depression is not ordinary depression
Bipolar disorder involves episodes of depression alongside episodes of mania or hypomania — periods of elevated mood, energy, and impulsivity. According to the National Institute of Mental Health, treatment usually centers on mood-stabilizing medication, psychotherapy, and steady, long-term coordination with a psychiatrist.
That distinction matters because the depressive phase of bipolar disorder does not behave exactly like unipolar depression, and some treatments that help unipolar depression can destabilize bipolar disorder. Any new treatment has to be weighed against that risk.
What research on ketamine suggests so far
Researchers have begun studying ketamine for bipolar depression, and the work is genuinely early: few studies, small participant groups, and short follow-up periods. Ketamine is not FDA-approved for bipolar depression, and esketamine (Spravato) approvals cover specific unipolar depression indications — not bipolar depression.
Early findings may turn out to be meaningful, or they may not hold up in larger studies. Either way, the current evidence is not strong enough to treat ketamine as an established option for bipolar depression, and we will not present it as one.
Why extra caution matters with bipolar disorder
Treatments that activate or elevate mood require particular caution in bipolar disorder because of the risk of triggering a switch into mania or hypomania. Mood stabilization comes first: any consideration of ketamine starts from a stable medication foundation, never from a change made to accommodate treatment.
For that reason, never stop or adjust a mood stabilizer or any other psychiatric medication on your own — not before a consultation, not ever — without the clinician who prescribed it. If your current regimen is not working well enough, that is a conversation to have with your psychiatrist.
How evaluation works — with your psychiatrist involved
If you ask us about ketamine for bipolar depression, your psychiatrist is part of the conversation from the start. With your permission, we review your diagnosis and episode history with them, confirm that your mood is currently stabilized, and consider together whether proceeding makes any sense at all.
Ketamine may be considered only in select cases — typically where standard treatments have been tried without adequate response — and always with specialist coordination. If your psychiatrist advises against it, that advice carries real weight with us.
- Mood stabilization verified before any treatment is discussed
- Your psychiatrist consulted, with your permission, throughout
- Off-label, early-evidence option — never a first step
Safety, monitoring, and crisis planning
Ketamine causes short-term side effects — including dissociation, nausea, and blood pressure changes — and the FDA has warned about risks tied to compounded ketamine products used without adequate safeguards. Screening, supervised sessions, and planned follow-up are how a responsible clinic manages those risks.
Bipolar disorder carries real crisis risk, and we treat that seriously. If you are having thoughts of self-harm, call or text 988 (Suicide & Crisis Lifeline) or call 911 now. Ketamine therapy is never an emergency treatment.
Common questions
No. Ketamine is FDA-approved as an anesthetic, and esketamine (Spravato) is approved for specific unipolar depression indications. Neither is approved for bipolar depression, so any such use is off-label and early in its evidence base.
No — never. Do not stop or change any psychiatric medication without the clinician who prescribed it. Evaluation here works around your current, stable regimen and involves your psychiatrist directly.
That concern is exactly why caution is required. Activating treatments can destabilize bipolar disorder, which is why mood stabilization comes first, your psychiatrist is involved in any decision, and monitoring continues throughout any treatment.
We treat disagreement as a reason to slow down, not to push forward. Your long-term relationship with your psychiatrist matters more than any single treatment decision, and we will not proceed without specialist coordination.
Sources & further reading
- Bipolar Disorder — National Institute of Mental Health. Accessed 2026-07-23. Overview of bipolar disorder, mood episodes, and standard treatment approaches.
- FDA warns patients and health care providers about potential risks associated with compounded ketamine products — U.S. Food and Drug Administration. Accessed 2026-07-23.
- 988 Suicide & Crisis Lifeline — Substance Abuse and Mental Health Services Administration. Accessed 2026-07-23.
Links point to external organizations. Clear Ketamine Therapy does not control their content.
Keep reading
- Am I a Candidate?Candidacy for ketamine therapy depends on your diagnosis, treatment history, health, and medications. Learn the factors clinicians weigh — and the next step.
- Safety & Side EffectsThe full safety picture: common short-term side effects, who should not receive ketamine, the FDA's compounded-ketamine warning, and our monitoring practices.
- What to ExpectA plain-language walkthrough of the full treatment process at our Tampa clinic — the evaluation, the sessions themselves, and the follow-up — including the parts that vary from person to person.
- Ketamine Therapy TampaPhysician-supervised ketamine therapy for adults in Tampa, Florida — what it is, who it may help, and how to take the first step.
Talk with our clinical team
A consultation is a conversation, not a commitment. Ask questions, share what you are comfortable sharing, and learn whether ketamine therapy may be worth considering for you.
Not for emergencies — call or text 988 or 911 if you are in crisis.